Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil

Sponsor
AstraZeneca
Study ID
NCT07370194
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This is a descriptive, retrospective study involving patients from private cardiology, nephrology, and dialysis clinics in Brazil who participated in the National Hyperkalaemia Diagnosis Campaign. The study used anonymised data from the Hi Technologies Ltda. database. The objective was to estimate and characterise the prevalence of hyperkalaemia (HK), as well as to analyse the demographic profile, clinical characteristics, risk factors and treatment patterns associated with total blood potassium levels.

Key Dates

Start date
Mar 31, 2026
Status verified
May 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
6,215 participants (estimated)

Primary Outcome Measure

Prevalence of Hyperkalemia [ Time Frame: through study completion, an average of 1 year ]

Central Contacts

Related Studies